James Jiao - Concepedia

Author

James Jiao

Janssen (United States)

Also Known As

James Jiao, James Juhui Jiao

Publications

826

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Janssen (Belgium)Pharmacyclics (United States)Texas Liver Institute The University of Texas Health Science Center at San Antonio

About

James Jiao is an author at Janssen (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	96
2	Pharmacology	3	3	68
3	Nutrition	1	1	16
4	Antimicrobial Pharmacokinetics	1	1	32
5	Clinical Pharmacology	1	1	16

James Jiao

Publications

805

Citations

H-Index

Page 1

	Year	Citations
Peginterferon alfa‐2a for hepatitis C after liver transplantation Naga Chalasani, Cosme Manzarbeitia, Peter Ferenci, Hepatology	2005	277
Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer Kim N., Jennifer L. Spratlin, Christian Kollmannsberger, The Journal of Clinical Pharmacology	2015	101
Abiraterone Acetate to Lower Androgens in Women With Classic 21-Hydroxylase Deficiency Richard J. Auchus, Elizabeth Buschur, Alice Y. Chang, The Journal of Clinical Endocrinology & Metabolism	2014	87
Stable isotope‐labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults Ronald de Vries, Johan W. Smit, Peter Hellemans, British Journal of Clinical Pharmacology	2015	70
Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer Ignacio Durán, Joan Carles, Iurie Bulat, Clinical Pharmacokinetics	2020	48
A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies Jan de Jong, Peter Hellemans, Severijn De Wilde, Leukemia & lymphoma/Leukemia and lymphoma	2018	47
Impact on abiraterone pharmacokinetics and safety: Open‐label drug–drug interaction studies with ketoconazole and rifampicin Apexa Bernard, Nicole Vaccaro, Milin Acharya, Clinical Pharmacology in Drug Development Drug SafetyDrug InteractionsAbiraterone PharmacokineticsPharmacological StudyMedicine	2014	32
Single‐dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment Thomas Marbury, Eric Lawitz, R.H. Stonerock, The Journal of Clinical Pharmacology	2013	31
Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study Jan de Jong, Peter Hellemans, James Jiao, Cancer Chemotherapy and Pharmacology Healthy SubjectsPharmacotherapyThorough Qt StudyMedicineQt Interval	2017	28
An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer Bodine P.S. Belderbos, Ronald de Wit, Caly Chien, Cancer Chemotherapy and Pharmacology	2018	26

Page 1